Abstract
How we approach contraception in today’s perimenopausal woman is drastically different from the approach of even 10 years ago, because the needs and options for this age group have changed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Advance report of final natality statistics, 1991. Monthly Vital Statistics Report 1993;42(3).
Ventura SJ, Martin JA, Taffel SM, Mathews TJ, Clarke CS. Advance report of final natality statistics, 1992. Monthly Vital Statistics Report 1994;43(5):1–88.
1994 Ortho Annual Birth Control Study. Ortho Pharmaceutical Corporation, Raritan, NJ.
Mischell DR Jr. Noncontraceptive benefits of oral contraceptives. J Reprod Med 1993;38(suppl):1021.
The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. Combination oral contraceptive use and the risk of endometrial cancer. JAMA 1987;257:796.
The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Engl J Med 1987;316:650.
Peipert JF, Gutmann J. Oral contraceptive risk assessment: a survey of 247 educated women. Obstet Gynecol 1993;82:112.
Connell EB. Rational use of oral contraceptives in the perimenopausal woman. J Reprod Med 1993;38(suppl):136.
Stergachis A, Shy KK, Grothaus LC, et al. Tubal sterilization and the long-term risk of hysterectomy. JAMA 1990;264(22):2893–8.
Rulin MC, Davidson AR, Philliber SG, Graves WL, Cushman LF. Long-term effect of tubal sterilization on menstrual indices and pelvic pain. Obstet Gynecol 1993;82(1):118–21.
ParaGard (Intrauterine Copper Contraceptive) Model T380A, Prescribing Information, 1995.
Harlap S, Kost K, Forrest JD. Preventing pregnancy, protecting health: a new look at birth control choices in the United States. New York: The Alan Guttmacher Institute, 1991.
Sivin I. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol 1992;78:291.
Farley TMM, Rosenberg MJ, Rowe PJ, et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992;339:785.
Alvarez F, Brache V, Fernandez E, et al. New insights on the mode of action of intrauterine contraceptive devices in women. Fertil Steril 1988;49:768.
Segal SJ, Alvarez-Sanchez F, Adejuwon CA, et al. Absence of chorionic gonadotropin in sera of women who use intrauterine devices. Fertil Steril 1985;44:214.
Darney PD, Atkinson E, Tanner S, et al. Acceptance and perceptions of Norplant among users in San Francisco, USA. Stud Fam Plann 1990;21:152.
Connell EB. Depot medroxyprogesterone acetate: clinical experience in the United States. Fem Pat, 1994;19:91.
Cundy T, Evans M, Roberts H, et al. Bone density in women receiving depot medroxyprogesterone acetate for contraception. Br Med J 1991;303:13–16.
Swartz DB, Wingo PA, Antarsh L, Smith JC. Female sterilizations in the United States, 1987. Fam Plann Perspect 1989;21:209.
Escobedo LG, Peterson HB, Grubb GS, Franks AL. Case-fatality rates for tubal sterilization in U.S. hospitals, 1979 to 1980. Am J Obstet Gynecol 1989;160:147.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Sulak, P.J. (1997). Contraceptive Needs and Options in Perimenopausal Women. In: Lobo, R.A. (eds) Perimenopause. Serono Symposia USA. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2288-0_22
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2288-0_22
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7488-9
Online ISBN: 978-1-4612-2288-0
eBook Packages: Springer Book Archive